Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
DIABETOLOGY / CLINICAL RESEARCH
The association between mixed exposure to per- and polyfluoroalkyl substances and the risk of diabetes
1
Department of Endocrinology, Yuyao People’s Hospital, Yuyao, Zhejiang, China
2
Department of Traditional Chinese Medicine, Yuyao People’s Hospital, Yuyao, Zhejiang, China
3
Department of Geriatrics, Yuyao People’s Hospital, Yuyao, Zhejiang, China
Submission date: 2024-02-20
Final revision date: 2024-03-27
Acceptance date: 2024-04-09
Online publication date: 2024-05-02
Corresponding author
Xiaoqing Zhan
Department of Traditional Chinese Medicine Yuyao People’s Hospital 315400 Yuyao, Zhejiang, China
Department of Traditional Chinese Medicine Yuyao People’s Hospital 315400 Yuyao, Zhejiang, China
KEYWORDS
TOPICS
ABSTRACT
Introduction:
This study aimed to investigate the relationship between exposure to per- and polyfluoroalkyl substances (PFASs) and the risk of diabetes by analyzing a large dataset from the National Health and Nutrition Examination Survey (NHANES).
Material and methods:
This study analyzed participants with complete data from the US NHANES database spanning from 2003 to 2018. Generalized linear regression models were used to examine the relationship between serum chemical concentrations and diabetes. Weighted quantiles and regression were employed to assess the association between mixed chemical exposure and diabetes. The ‘mixture effect’ between chemicals and diabetes was estimated using a quantile g-computation model.
Results:
The study involved a total of 11,780 participants, with 1,451 individuals having diabetes and 10,329 not having diabetes. Logistic regression analysis was utilized to investigate the relationship between five PFAS chemicals and the risk of diabetes, while controlling for all covariates. The results indicated that none of the PFAS chemicals exhibited a statistically significant association with an increased risk of diabetes. However, when exploring the positive and negative constraint models of the weighted quantile sum (WQS), the coefficient of the chemical mixing index displayed a strong correlation with diabetes in model III, even after adjusting for covariates. Additionally, an evaluation of the ‘mixture effect’ using quantile g-computation revealed that among the five chemicals, the combined exposure effect of perfluorononanoate (PFNA) on diabetes was positive, whereas exposure to the other four chemicals had a negative impact.
Conclusions:
The study findings suggest a possible association between PFASs and increased risk of diabetes, particularly highlighting PFNA’s positive correlation with the combined exposure effect on diabetes.
This study aimed to investigate the relationship between exposure to per- and polyfluoroalkyl substances (PFASs) and the risk of diabetes by analyzing a large dataset from the National Health and Nutrition Examination Survey (NHANES).
Material and methods:
This study analyzed participants with complete data from the US NHANES database spanning from 2003 to 2018. Generalized linear regression models were used to examine the relationship between serum chemical concentrations and diabetes. Weighted quantiles and regression were employed to assess the association between mixed chemical exposure and diabetes. The ‘mixture effect’ between chemicals and diabetes was estimated using a quantile g-computation model.
Results:
The study involved a total of 11,780 participants, with 1,451 individuals having diabetes and 10,329 not having diabetes. Logistic regression analysis was utilized to investigate the relationship between five PFAS chemicals and the risk of diabetes, while controlling for all covariates. The results indicated that none of the PFAS chemicals exhibited a statistically significant association with an increased risk of diabetes. However, when exploring the positive and negative constraint models of the weighted quantile sum (WQS), the coefficient of the chemical mixing index displayed a strong correlation with diabetes in model III, even after adjusting for covariates. Additionally, an evaluation of the ‘mixture effect’ using quantile g-computation revealed that among the five chemicals, the combined exposure effect of perfluorononanoate (PFNA) on diabetes was positive, whereas exposure to the other four chemicals had a negative impact.
Conclusions:
The study findings suggest a possible association between PFASs and increased risk of diabetes, particularly highlighting PFNA’s positive correlation with the combined exposure effect on diabetes.
REFERENCES (34)
2.
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
3.
Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med 2017; 15: 131.
4.
Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-5.
5.
Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-41.
6.
Qi W, Clark JM, Timme-Laragy AR, Park Y. Per- and polyfluoroalkyl substances and obesity, type 2 diabetes and non-alcoholic fatty liver disease: a review of epidemiologic findings. Toxicol Environ Chem 2020; 102: 1-36.
7.
Buck RC, Franklin J, Berger U, et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag 2011; 7: 513-41.
8.
Meng L, Song B, Lu Y, et al. The occurrence of perand polyfluoroalkyl substances (PFASs) in fluoropolymer raw materials and products made in China. J Environ Sci (China) 2021; 107: 77-86.
9.
Zhang Z, Sarkar D, Biswas JK, Rupali Datta R. Biodegradation of per- and polyfluoroalkyl substances (PFAS): a review. Bioresour Technol 2022; 344: 126223.
10.
Brusseau ML, Anderson RH, Guo B. PFAS concentrations in soils: background levels versus contaminated sites. Sci Total Environ 2020; 740: 140017.
11.
Domingo JL, Nadal M. Human exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water: a review of the recent scientific literature. Environ Res 2019; 177: 108648.
12.
Clara M, Scheffknecht C, Scharf S, Weiss S, Gans O. Emissions of perfluorinated alkylated substances (PFAS) from point sources: identification of relevant branches. Water Sci Technol 2008; 58: 59-66.
13.
Wee SY, Aris AZ. Environmental impacts, exposure pathways, and health effects of PFOA and PFOS. Ecotoxicol Environ Saf 2023; 267: 115663.
14.
Gui SY, Qiao JC, Xu KX, et al. Association between per-and polyfluoroalkyl substances exposure and risk of diabetes: a systematic review and meta-analysis. J Exp Sci Environ Epidemiol 2023; 33: 40-55.
15.
Nguyen MA, Wiberg K, Ribeli E, et al. Spatial distribution and source tracing of per- and polyfluoroalkyl substances (PFASs) in surface water in Northern Europe. Environ Pollut 2017; 220: 1438-46.
16.
Prevedouros K, Cousins IT, Buck RC, Korzeniowski SH. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 2006; 40: 32-44.
17.
Xie LN, Wang XC, Dong XJ, et al. Concentration, spatial distribution, and health risk assessment of PFASs in serum of teenagers, tap water and soil near a Chinese fluorochemical industrial plant. Environ Int 2021; 146: 106166.
18.
Zheng XQ, Shi Y, Lu YL, Xu X. Growth inhibition and DNA damage in the earthworm (Eisenia fetida) exposed to perfluorooctane sulphonate and perfluorooctanoic acid. Chem Ecol 2016; 32: 103-16.
19.
Caron-Beaudoin É, Ayotte P, Sidi EA, et al. Exposure to perfluoroalkyl substances (PFAS) and associations with thyroid parameters in First Nation children and youth from Quebec. Environ Int 2019; 128: 13-23.
20.
Carrico C, Gennings C, Wheeler DC, Factor-Litvak P. Characterization of weighted quantile sum regression for highly correlated data in a risk analysis setting. J Agric Biol Environ Stat 2015; 20: 100-20.
21.
Schmidt S. Quantile g-computation: a new method for analyzing mixtures of environmental exposures. Environ Health Perspect 2020; 128: 104004.
22.
Domazet SL, Grøntved A, Timmermann AG, et al. Longitudinal associations of exposure to perfluoroalkylated substances in childhood and adolescence and indicators of adiposity and glucose metabolism 6 and 12 years later: the European Youth Heart Study. Diabetes Care 2016; 39: 1745-51.
23.
Kim JH, Park HY, Jeon JD, et al. The modifying effect of vitamin C on the association between perfluorinated compounds and insulin resistance in the Korean elderly: a double-blind, randomized, placebo-controlled crossover trial. Eur J Nutr 2016; 55: 1011-20.
24.
Cardenas A, Gold DR, Hauser R, et al. Plasma concentrations of per- and polyfluoroalkyl substances at baseline and associations with glycemic indicators and diabetes incidence among high-risk adults in the Diabetes Prevention Program Trial. Environ Health Perspect 2017; 125: 107001.
25.
Duan Y, Sun H, Yao Y, et al. Distribution of novel and legacy per-/polyfluoroalkyl substances in serum and its associations with two glycemic biomarkers among Chinese adult men and women with normal blood glucose levels. Environ Int 2020; 134: 105295.
26.
Liu HS, Wen LL, Chu PL, Lin CY. Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013-2014. Environ Pollut 2018; 232: 73-9.
27.
Nelson JW, Hatch EE, Webster TF. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 2010; 118: 197-202.
28.
Lundin JI, Alexander BH, Olsen GW, Church TR. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 2009; 20: 921-8.
29.
Donat-Vargas C, Bergdahl IA, Tornevi A, et al. Perfluoroalkyl substances and risk of type II diabetes: a prospective nested case-control study. Environ Int 2019; 123: 390-8.
30.
MacNeil J, Steenland NK, Shankar A, Ducatman A. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). Environ Res 2009; 109: 997-1003.
31.
Conway B, Innes KE, Long D. Perfluoroalkyl substances and beta cell deficient diabetes. J Diabetes Complications 2016; 30: 993-8.
32.
Zhang L, Duan X, Sun W, Sun H. Perfluorooctane sulfonate acute exposure stimulates insulin secretion via GPR40 pathway. Sci Total Environ 2020; 726: 138498.
33.
Sen P, Qadri S, Luukkonen PK, et al. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease. J Hepatol 2022; 76: 283-93.
34.
DeWitt JC. Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances. Springer 2015.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
